Industry

The Week In Review provides an overview of the past week’s top healthcare content, including industry news and trends, Mayo Clinic and Mayo Medical Laboratories news and upcoming events. Top highlights this week include breast cancer, HPV vaccine, WellStar Health System collaboration, prostate cancer and UnitedHealth-Mayo venture Optum Labs.

By Kelley Luedke • February 14, 2014

The Week In Review provides an overview of the past week’s top healthcare content, including industry news and trends, Mayo Clinic and Mayo Medical Laboratories news and upcoming events. Top highlights this week include anti-smoking campaign, cancer tidal wave, Minnesota Timberwolves and Mayo Clinic partnership, Dr. John Noseworthy on health care and Destination Medical Center budget.

By Kelley Luedke • February 6, 2014

The Week In Review provides an overview of the past week’s top healthcare content, including industry news and trends, Mayo Clinic and Mayo Medical Laboratories news and upcoming events. Top highlights this week include patient health care costs, genetic testing, health insurance updates, Muppets’ mini-makeover and pertussis.

By Kelley Luedke • January 24, 2014

The Week In Review provides an overview of the past week’s top healthcare content, including industry news and trends, Mayo Clinic and Mayo Medical Laboratories news and upcoming events. Top highlights this week include stem cell research, multiple sclerosis, modernizing healthcare, Mayo Clinic’s 150th year anniversary and breast cancer risks.

By Kelley Luedke • January 23, 2014

The Week In Review provides an overview of the past week’s top healthcare content, including industry news and trends, Mayo Clinic and Mayo Medical Laboratories news and upcoming events. Top highlights this week include experimental gene therapy, health care law, the flu, Mayo Clinic Destination Medical Center and a new laboratory test.

By Kelley Luedke • January 16, 2014

Currently, several United States Food and Drug Administration (FDA)-approved specific inhibitors of certain molecular targets are effective for treating patients with non-small cell lung cancer (NSCLC). Patients should undergo EGFR and ALK testing on their tumors using FFPE tissues.

By Kelley Luedke • January 2, 2014

With Thanksgiving right around the corner, turkey is on everyone’s mind. To make this time of year a fun and safe one, the Centers for Disease Control and Prevention (CDC) has compiled a few Turkey Basics when it comes to preparing food for the holidays.

By Kelley Luedke • November 26, 2013

Mayo Clinic Care Network adds first Colorado member, Aspen Valley Hospital. Aspen Valley Hospital is a 25-bed critical access hospital that has received national awards for patient satisfaction from Avatar International and was recently named one of the top 20 Critical Access Hospitals in the country.

By Kelley Luedke • November 20, 2013

Mayo Clinic and Mayo Medical Laboratories have signed a collaboration agreement with bioTheranostics to offer CancerTYPE ID® molecular cancer classification test, as part of its surgical pathology consultations, to aid in the management of patients with metastatic cancer.

By Kelley Luedke • November 4, 2013

Melanoma comprises only 10 percent of all skin cancers, but is responsible for approximately 90 percent of all skin-cancer mortality. Mayo Medical Laboratories’ melanoma FISH assay assists in the diagnosis of malignant melanoma, differentiating malignant melanoma from benign melanocytic lesions.

By Kelley Luedke • November 1, 2013

Systems engineers from the Mayo Clinic Department of Laboratory Medicine and Pathology (DLMP) were recently interviewed by “Clinic Lab Products” for its October coverage of Lean and Six Sigma laboratory solutions. Interviewed for the article were Rich Carlson and Matt A. Clark.

By Kelley Luedke • October 30, 2013

Clostridium difficile, an anaerobic spore-forming gram-positive bacillus, is the most important cause of antibiotic-associated diarrhea and pseudomembranous colitis. Polymerase chain reaction (PCR) assays have been developed to detect genetic markers in the PaLoc region of C difficile. While it is the most efficient direct method for laboratory diagnosis of C difficile infection, some laboratories may prefer the algorithmic approach using PCR as a confirmatory test for the presence of toxin.

By Kelley Luedke • September 1, 2013

Jaundice is a very common condition in newborn infants that is most often benign. However, acute and chronic bilirubin encephalopathy (acute or chronic neurologic damage resulting from high serum bilirubin levels) does still occur. Mayo Clinic used a screening algorithm to determine how to best use and interpret TcB values from healthy newborns.

By Kelley Luedke • July 1, 2013